Evidence map›Paper›PMID 30575729›Full record

ArticleNature communications2018

Distinct adaptive mechanisms drive recovery from aneuploidy caused by loss of the Ulp2 SUMO protease.

Hong-Yeoul Ryu, Francesc López-Giráldez, James Knight, Soo Seok Hwang, Christina Renner, Stefan G Kreft, Mark Hochstrasser

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Histone modification inComputational and structural biotechnology journal · 2023
    Review
  10. Article
  11. Review
  12. SUMOylation and Major Depressive Disorder.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Effects of aneuploidy on cell behaviour and function.Nature reviews. Molecular cell biology · 2022
    Review
  15. Review
  16. Article
  17. Histone sumoylation and chromatin dynamics.Nucleic acids research · 2021
    Review
  18. Article
  19. SUMO and cellular adaptive mechanisms.Experimental & molecular medicine · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hong-Yeoul RyuDepartment of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT, 06520, USA.
Francesc López-GiráldezYale Center for Genome Analysis, Yale University, New Haven, CT, 06520, USA.ORCID http://orcid.org/0000-0001-7476-9822
James KnightYale Center for Genome Analysis, Yale University, New Haven, CT, 06520, USA.
Soo Seok HwangDepartment of Immunobiology, Yale University, New Haven, CT, 06520, USA.ORCID http://orcid.org/0000-0002-1635-4191
Christina RennerDepartment of Biology, Molecular Microbiology, University of Konstanz, Universitaetsstrasse 10, 78457, Konstanz, Germany.
Stefan G KreftDepartment of Biology, Molecular Microbiology, University of Konstanz, Universitaetsstrasse 10, 78457, Konstanz, Germany.
Mark HochstrasserDepartment of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT, 06520, USA. mark.hochstrasser@yale.edu.
Yale University · USUniversity of Konstanz · DE

Funding

FUNCTIONS AND MECHANISMS OF DEUBIQUITINATING ENZYMESR01GM053756 · NIGMS · YALE UNIVERSITY · PI HOCHSTRASSER, MARK W · 1996 to 2019
$6.5M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysiS10OD018521 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2015 to 2015
$890k
NIGMS NIH HHS R01 GM053756NIH HHS S10 OD018521NIH HHS S10 OD030363
6 · The paper itself

Abstract

In response to acute loss of the Ulp2 SUMO-specific protease, yeast become disomic for chromosome I (ChrI) and ChrXII. Here we report that ChrI disomy, which creates an adaptive advantage in part by increasing the dosage of the Ccr4 deadenylase, was eliminated by extended passaging. Loss of aneuploidy is often accompanied by mutations in essential SUMO-ligating enzymes, which reduced polySUMO-conjugate accumulation. The mRNA levels for almost all ribosomal proteins increase transiently upon initial loss of Ulp2, but elevated Ccr4 levels limit excess ribosome formation. Notably, extended passaging leads to increased levels of many small nucleolar RNAs (snoRNAs) involved in ribosome biogenesis, and higher dosage of three linked ChrXII snoRNA genes suppressed ChrXII disomy in ulp2Δ cells. Our data reveal that aneuploidy allows rapid adaptation to Ulp2 loss, but long-term adaptation restores euploidy. Cellular evolution restores homeostasis through countervailing mutations in SUMO-modification pathways and regulatory shifts in ribosome biogenesis.

Indexed as

Adaptation, BiologicalAneuploidyEndopeptidasesPoint MutationRibosomal ProteinsRNA, Small NucleolarSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSmall Ubiquitin-Related Modifier ProteinsUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9EndopeptidasesRibosomal ProteinsRNA, Small NucleolarSaccharomyces cerevisiae ProteinsSmall Ubiquitin-Related Modifier ProteinsUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9ULP2 protein, S cerevisiae

Identifiers

PMID30575729
PMCPMC6303320
OpenAlexW2903871671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.